Anaptysbio (ANAB) Enterprise Value (2016 - 2026)
Anaptysbio (ANAB) reported Enterprise Value of -$286.5 million for Q1 2026, up 15.73% on a YoY basis from -$247.5 million in Q1 2025, and up 8.08% quarter-over-quarter from -$311.6 million in Q4 2025.
Anaptysbio (ANAB) Enterprise Value (2016 - 2026) Analysis & Trends
Anaptysbio has reported Enterprise Value for 11 years, with the latest figure at -$286.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 15.73% year-over-year to -$286.5 million; the trailing twelve-month figure through Mar 2026 stood at -$286.5 million (up 15.73% YoY), and the FY2025 full-year result was -$311.6 million, up 19.13% from the prior year.
- Enterprise Value for Q1 2026 stood at -$286.5 million, up from -$311.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$249.0 million in Q3 2025, with the low at -$505.6 million in Q1 2022.
- Historically, Enterprise Value has averaged -$380.6 million across 5 years, with a median of -$390.9 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 33.05% — and 2025, when it soared 42.12%.
- Anaptysbio's Enterprise Value stood at -$441.2 million in 2022, then grew by 11.41% to -$390.9 million in 2023, then rose by 1.41% to -$385.4 million in 2024, then climbed by 19.13% to -$311.6 million in 2025, then advanced by 8.08% to -$286.5 million in 2026.
- The last three Enterprise Value figures came in at -$286.5 million (Q1 2026), -$311.6 million (Q4 2025), and -$249.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | -286.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -286.46 Mn |
| Dec 31, 2025 | -311.64 Mn |
| Sep 30, 2025 | -248.96 Mn |
| Jun 30, 2025 | -265.71 Mn |
| Mar 31, 2025 | -339.94 Mn |
| Dec 31, 2024 | -385.37 Mn |
| Sep 30, 2024 | -430.12 Mn |
| Jun 30, 2024 | -350.80 Mn |
| Mar 31, 2024 | -354.67 Mn |
| Dec 31, 2023 | -390.90 Mn |
| Sep 30, 2023 | -413.05 Mn |
| Jun 30, 2023 | -429.49 Mn |
| Mar 31, 2023 | -431.15 Mn |
| Dec 31, 2022 | -441.24 Mn |
| Sep 30, 2022 | -442.97 Mn |
| Jun 30, 2022 | -442.15 Mn |
| Mar 31, 2022 | -505.62 Mn |
| Dec 31, 2021 | -548.10 Mn |
| Sep 30, 2021 | -374.06 Mn |
| Jun 30, 2021 | -332.31 Mn |